ROCKWELL MEDICAL, INC. Variable Lease, Cost
ROCKWELL MEDICAL, INC. (RMTI) reported Variable Lease, Cost of $97.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. variable lease, cost for the quarter ending 2026-06-30 was $97.00K, a 29.20% decline year-over-year.
- ROCKWELL MEDICAL, INC. variable lease, cost for the quarter ending 2026-03-31 was $70.00K, a 45.31% decline year-over-year.
- ROCKWELL MEDICAL, INC. variable lease, cost for the quarter ending 2025-12-31 was $144.00K, a 9.09% increase year-over-year.
- ROCKWELL MEDICAL, INC. variable lease, cost for the quarter ending 2025-09-30 was $146.00K, a 15.87% increase year-over-year.
- ROCKWELL MEDICAL, INC. variable lease, cost for fiscal 2025 was $555.00K, a 9.25% increase from fiscal 2024.
- ROCKWELL MEDICAL, INC. variable lease, cost for fiscal 2024 was $508.00K, a 2.21% increase from fiscal 2023.
- ROCKWELL MEDICAL, INC. variable lease, cost for fiscal 2023 was $497.00K, a 28.09% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. variable lease, cost for fiscal 2022 was $388.00K, a 4.02% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $97.00K 10-Q · filed 2026-08-13 | $167.00K 10-Q · filed 2026-08-13 | $311.00K derived: sum of 3 quarters · filed 2026-08-13 | $457.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $70.00K 10-Q · filed 2026-05-07 | $214.00K derived: sum of 2 quarters · filed 2026-05-07 | $360.00K derived: sum of 3 quarters · filed 2026-05-07 | $497.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $290.00K derived: sum of 2 quarters · filed 2026-03-26 | $427.00K derived: sum of 3 quarters · filed 2026-08-13 | $555.00K 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $146.00K 10-Q · filed 2025-11-12 | $283.00K derived: sum of 2 quarters · filed 2026-08-13 | $411.00K 10-Q · filed 2025-11-12 | $543.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $137.00K 10-Q · filed 2026-08-13 | $265.00K 10-Q · filed 2026-08-13 | $397.00K derived: sum of 3 quarters · filed 2026-08-13 | $523.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $128.00K 10-Q · filed 2026-05-07 | $260.00K derived: sum of 2 quarters · filed 2026-05-07 | $386.00K derived: sum of 3 quarters · filed 2026-05-07 | $514.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $258.00K derived: sum of 2 quarters · filed 2026-03-26 | $386.00K derived: sum of 3 quarters · filed 2026-03-26 | $508.00K 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $126.00K 10-Q · filed 2025-11-12 | $254.00K derived: sum of 2 quarters · filed 2025-11-12 | $376.00K 10-Q · filed 2025-11-12 | $537.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $128.00K 10-Q · filed 2025-08-14 | $250.00K 10-Q · filed 2025-08-14 | $411.00K derived: sum of 3 quarters · filed 2025-08-14 | $523.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $122.00K 10-Q · filed 2025-05-12 | $283.00K derived: sum of 2 quarters · filed 2025-05-12 | $395.00K derived: sum of 3 quarters · filed 2025-05-12 | $504.00K derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $273.00K derived: sum of 2 quarters · filed 2025-03-20 | $382.00K derived: sum of 3 quarters · filed 2025-03-20 | $497.00K 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $112.00K 10-Q · filed 2024-11-12 | $221.00K derived: sum of 2 quarters · filed 2024-11-12 | $336.00K 10-Q · filed 2024-11-12 | $437.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $109.00K 10-Q · filed 2024-08-08 | $224.00K 10-Q · filed 2024-08-08 | $325.00K derived: sum of 3 quarters · filed 2024-08-08 | $426.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $115.00K 10-Q · filed 2024-05-14 | $216.00K derived: sum of 2 quarters · filed 2024-05-14 | $317.00K derived: sum of 3 quarters · filed 2024-05-14 | $409.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $202.00K derived: sum of 2 quarters · filed 2024-03-21 | $294.00K derived: sum of 3 quarters · filed 2024-03-21 | $388.00K 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $101.00K 10-Q · filed 2023-11-14 | $193.00K derived: sum of 2 quarters · filed 2023-11-14 | $287.00K 10-Q · filed 2023-11-14 | $375.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $92.00K 10-Q · filed 2023-08-14 | $187.00K 10-Q · filed 2023-08-14 | $274.00K derived: sum of 3 quarters · filed 2023-08-14 | $368.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $95.00K 10-Q · filed 2023-05-15 | $182.00K derived: sum of 2 quarters · filed 2023-05-15 | $276.00K derived: sum of 3 quarters · filed 2023-05-15 | $366.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $181.00K derived: sum of 2 quarters · filed 2023-03-30 | $271.00K derived: sum of 3 quarters · filed 2023-03-30 | $373.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $94.00K 10-Q · filed 2022-11-14 | $184.00K derived: sum of 2 quarters · filed 2022-11-14 | $286.00K 10-Q · filed 2022-11-14 | $371.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $90.00K 10-Q · filed 2022-08-15 | $192.00K 10-Q · filed 2022-08-15 | $277.00K derived: sum of 3 quarters · filed 2022-08-15 | $367.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $102.00K 10-Q · filed 2022-05-16 | $187.00K derived: sum of 2 quarters · filed 2022-05-16 | $277.00K derived: sum of 3 quarters · filed 2022-05-16 | $400.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $175.00K derived: sum of 2 quarters · filed 2022-04-08 | $298.00K derived: sum of 3 quarters · filed 2022-04-08 | $488.00K 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $90.00K 10-Q · filed 2021-11-15 | $213.00K derived: sum of 2 quarters · filed 2021-11-15 | $403.00K 10-Q · filed 2021-11-15 | $462.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $123.00K 10-Q · filed 2021-08-16 | $122.86K 10-Q · filed 2020-08-10 | $312.00K 10-Q · filed 2021-08-16 | $312.15K 10-Q · filed 2020-08-10 | $372.00K derived: sum of 3 quarters · filed 2021-08-16 | $462.00K derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $189.00K 10-Q · filed 2021-05-17 | $189.28K 10-Q · filed 2020-05-11 | $249.00K derived: sum of 2 quarters · filed 2021-05-17 | $339.00K derived: sum of 3 quarters · filed 2021-05-17 | $417.24K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $150.00K derived: sum of 2 quarters · filed 2021-03-31 | $228.24K derived: sum of 3 quarters · filed 2021-03-31 | $318.00K 10-K · filed 2021-03-31 | $317.79K 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $90.00K 10-Q · filed 2020-11-09 | $90.41K 10-Q · filed 2019-11-12 | $168.24K derived: sum of 2 quarters · filed 2020-11-09 | $258.00K 10-Q · filed 2020-11-09 | $258.49K 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $78.24K 10-Q · filed 2020-08-10 | $168.08K 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | $89.84K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |